Prostate Cancer Clinical Trials in Baltimore, MD

Prostate Cancer Clinical Trials in Baltimore, MD

View the best 10 prostate cancer medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Prostate Cancer clinical trial.

Trials in Baltimore, Maryland

Here are the top 10 medical studies for prostate cancer in Baltimore, Maryland

Image of Mobile Infirmary Medical Center in Mobile, United States.

Intensity-Modulated Radiation Therapy (IMRT) +1 More

Radiation Therapy

Recruiting2 awardsPhase 3
This trial compares two types of radiation therapy to treat prostate cancer. Stereotactic body radiation therapy may work better than intensity-modulated radiation therapy.
Image of Maryland Proton Treatment Center in Baltimore, United States.

Prostate radiation (XRT) +2 More

Radiation Therapy

Recruiting1 awardPhase 2
This trial is testing whether a new drug can help prostate cancer patients who have failed other treatments and have 3 or fewer bone or soft tissue metastases.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Apalutamide

Antiandrogen

Recruiting2 awardsPhase 3
This trial is testing whether adding apalutamide to standard treatment, with or without targeted radiation therapy, helps patients with prostate cancer that has come back after treatment.
Image of Johns Hopkins Hospital in Baltimore, United States.

Testosterone Undecanoate

Hormone Therapy

Recruiting1 awardPhase 2
This trial will analyze the effects of oral testosterone therapy given on a schedule of seven days of therapy followed by seven days of no therapy for a 28 day cycle in men with metastatic castrate resistant prostate cancer.
Image of Johns Hopkins in Baltimore, United States.

Flutamide

Androgen Receptor Partial Agonist

Recruiting2 awardsPhase < 1
This trial will test if flutamide can help treat prostate cancer by creating double strand breaks in the DNA of cancer cells.
Image of Sibley Memorial Hospital in Washington, United States.

LY2157299 +1 More

TGF-β Receptor Inhibitor

Recruiting1 awardPhase 2
This trial is testing if adding LY2157299 to enzalutamide helps people with metastatic castration-resistant prostate cancer live longer without their disease getting worse.
Image of Biogenix Molecular LLC in Miami, United States.

177Lu-TLX591

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial aims to see how well 177Lu-TLX591 works and how safe it is for patients with advanced prostate cancer that has spread, despite previous treatment with medicines that target the androgen
Image of Colorado Clinical Research in Lakewood, United States.

Androgen-deprivation Therapy (ADT) +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial aims to see if using ADT intermittently can improve survival rate & reduce hot flashes in men with mCSPC, with PSA levels <0.2 ng/mL after 6 months of treatment.
Image of Urology Centers Of Alabama in Homewood, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
Image of VA Greater Los Angeles Healthcare System,Cancer Center Research in Los Angeles, United States.

[177Lu]Ludotadipep

Radiopharmaceutical

Recruiting2 awardsPhase 1 & 2
This trial tests the safety and effectiveness of a radioactive drug called [177Lu]Ludotadipep. The drug works by delivering radiation directly to certain cells to treat the condition. Lutetium-177 (177Lu) has been widely used in targeted therapy, particularly in peptide receptor radionuclide therapy (PRRT) for treating neuroendocrine tumors.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.